Didier Raoul, a French infectious diseases doctor, said that in France 24 patients with coronavirus took the anti-malarial drug Plaquenil, after six days only 25% of people remained sick. French authorities plan to continue research on the drug.
Clinical studies in France have shown the effectiveness of the antimalarial chloroquine in treating coronavirus. This was told by the French infectious diseases doctor, the head of the Mediterranean Institute of Infectious Diseases in Marseille, Didier Raul, The Connexion reported on March 17.
On March 16, a recording of the presentation of the research results was published on the institute’s YouTube channel.
Raoul said that 24 patients participated in the study – the first infected in the south-east of France, they voluntarily agreed to participate in the experiment. For 10 days, patients took Plaquenil (the name by which chloroquine is sold), by 600 mcg daily.
Six days after the start of the intake, he said, only 25% of patients remained ill. Moreover, among patients who did not take Plaquenil, after six days of infection, was 90%.
Earlier, Chinese researchers claimed the effectiveness of chloroquine in coronavirus.
On March 17, the official representative of the French government, Sibet Ndiaye, called the results of the Raoul study promising, but noted that there is no scientific evidence that such treatment works, France 3 Régions reported. French authorities plan to continue research at the University Hospital of Lille.
French pharmaceutical company Sanofi says it’s ready to give the French government “millions of doses” Plaquenil, which is enough to treat about 300 thousand patients, France 24 informs.
Interviewed France 24 and Europe 1 experts noted side effects from taking the drug, especially in case of overdose. Firstly, with malaria, Plaquenil is usually not recommended for people over 65 years old (namely, for this age group, coronavirus is especially dangerous). Secondly, as nephrologist Gilbert Dere explained, Plaquenil negatively affects the retina, which can lead to loss of vision, as well as heart function.
Special medicines for coronavirus infection COVID-19 do not yet exist, now only symptomatic treatment is given for this disease. The World Health Organization noted that a number of drugs can help to improve well-being and alleviate the symptoms of COVID-19, but so far there is no evidence that any drug can prevent or treat this disease.
An outbreak of coronavirus infection COVID-19 began in late 2019 in China. March 11, the World Health Organization announced the spread of coronavirus pandemic. According to WHO, on the evening of March 18, 207 855 people were infected with coronavirus in more than 160 countries, 8648 people died. The largest number of cases in China, Italy and Iran.